Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 268-275 , September 2006

Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes

  • Eun Seok Kang

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Gu, 120-752 Seoul, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University, Republic of Korea
    • These authors equally contributed in this work.
    • ,
  • Moonsuk Nam

      Affiliations

    • Department of Internal Medicine, Inha University College of Medicine, Republic of Korea
    • These authors equally contributed in this work.
    • ,
  • Hye Joo Kim

      Affiliations

    • Brain Korea 21 Project for Medical Science, Yonsei University, Republic of Korea
    • ,
  • Hyeong Jin Kim

      Affiliations

    • Department of Internal Medicine, Kwandong University College of Medicine, Republic of Korea
    • ,
  • Sung Min Myoung

      Affiliations

    • Department of Biostatistics, Yonsei University College of Medicine, Republic of Korea
    • ,
  • Yumie Rhee

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Gu, 120-752 Seoul, Republic of Korea
    • ,
  • Chul Woo Ahn

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Gu, 120-752 Seoul, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University, Republic of Korea
    • ,
  • Bong Soo Cha

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Gu, 120-752 Seoul, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University, Republic of Korea
    • ,
  • Hyun Chul Lee

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Gu, 120-752 Seoul, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 2228 1943; fax: +82 2 393 6884.

Received 28 November 2005 ,Revised 4 January 2006 ,Accepted 27 January 2006.

References 

  1. Kim YM, Cha BS, Kim DJ, Choi SH, Kim SK, Ahn CW, et al. Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus. Diab. Res. Clin. Pract. 2005;67:43–52
  2. Haffner SM, D’Agostino J, Mykkanen L, Tracy R, Howard B, Rewers M, et al. Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diab. Care. 1999;22:562–568
  3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab. Care. 2001;24:683–689
  4. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM, et al. Variation in the Calpain-10 gene affects blood glucose levels in the British population. Diabetes. 2002;51:247–250
  5. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, et al. Haplotype combinations of Calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes. 2002;51:1622–1628
  6. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, et al. Role of Calpain-10 gene variants in familial type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 2002;87:650–654
  7. Iwasaki N, Horikawa Y, Tsuchiya T, Kitamura Y, Nakamura T, Tanizawa Y, et al. Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population. J. Hum. Genet. 2005;50:92–98
  8. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and the prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diab. Care. 2003;52:1210–1214
  9. Meigs JB, Wilson PWF, Nathan DM, D’Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring studies. Diabetes. 2003;52:2160–2167
  10. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diab. Care. 2003;26:575–581
  11. Hanley AJG, Wagenknecht LE, D’Agostino RB, Zinman B, Haffner SM. Identification of subjects with insulin resistance and β-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003;52:2740–2747
  12. Report of a WHO Consultation, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Geneva, 1999.
  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  14. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1, diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diab. Med. 1998;15:539–553
  15. World Health Organization , International Association for the Study of Obesity , International Obesity Task Force . The Asia-Pacific Perspective, Redefining Obesity and its Treatment. Sydney: Health Communications Australia Pty Ltd.; 2000;
  16. Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW STELLAR Study Group. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am. J. Cardiol. 2005;95:360–366
  17. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, et al. Studies of association between the gene for Calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet. 2001;69:544–552
  18. Horikawa Y, Oda N, Yu L, Imamura S, Fujiwara K, Makino M, et al. Genetic variations in Calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab. 2003;88:244–247
  19. Haplotyper Program, Department of Statistics, Harvard University, Boston, available from http://www.people.fas.harvard.edu/∼junliu/Haplo.
  20. Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, et al. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diab. Care. 2005;28:1139–1144
  21. Niu T, Qin ZS, Xu X, Liu JS. Bayesian haplotype inference for multiple linked single-nucleotide polymorphism. Am. J. Hum. Genet. 2002;158–169
  22. Power Calculator Program, Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, available from http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize.
  23. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  24. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diab. Care. 2005;28:385–390
  25. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  26. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diab. Care. 2003;26:3160–3167
  27. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, et al. Variants within the Calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes. 2002;51:3561–3567
  28. Patel YM, Lane MD. Role of Calpain in adipocyte differentiation. Proc. Natl. Acad. Sci. U.S.A. 1999;96:1279–1284
  29. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diab. Care. 2003;26:861–867
  30. Roberts AW, Evans M. The metabolic syndrome, inflammation and cardiovascular disease in type 2 diabetes. Curr. Opin. Lipidol. 2004;15:89–91
  31. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the Calpain 10 gene (CAPN10) is associated with type 2 diabetes mellitus. Nat. Genet. 2000;26:163–175
  32. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J, et al. Homozygous combination of Calpain-10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur. J. Endocrinol. 2002;146:695–699
  33. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, et al. Variation in three single nucleotide polymorphisms in the Calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes. 2002;51:1644–1648
  34. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diab. Res. Clin. Pract. 2002;56:147–152
  35. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, et al. Type 2 diabetes an three Calpain-10 gene polymorphisms in Samoans: no evidence of association. Am. J. Hum. Genet. 2001;69:1236–1244
  36. Chen Y, Kittles R, Zhou J, Chen G, Adeyemo A, Panguluri RK, et al. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Ann. Epidemiol. 2005;15:153–159
  37. Wu B, Takahashi J, Fu M, Cheng H, Matsumura S, Taniguchi H. Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population. Diab. Res. Clin. Pract. 2005;68:155–161
  38. Stumvoll M, Fritsche A, Madaus A, Stefan N, Weisser M, Machicao F, et al. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes. 2001;50:2161–2163
  39. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen G-Q, et al. A Calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 2000;106:69–73
  40. Paul DS, Harmon AW, Winston CP, Pate YM. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem. J. 2003;15:625–632
  41. Ridderstrale M, Parikh H, Groop L. Calpain 10 and type 2 diabetes: are we getting closer to an explanation?. Curr. Opin. Clin. Nutr. Metab. Care. 2005;8:361–366
  42. Turner MD, Cassell PG, Hitman GA. Calpain-10: from genome search to function. Diab. Metab. Res. Rev. 2005;21:505–514
  43. Zhou Y-P, Sreenan S, Pan C-Y, Currie KPM, Bindokas VP, Horikawa Y, et al. A 48-hour exposure of pancreatic islets to Calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism. 2003;52:528–534
  44. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, et al. Calpains play a role in insulin secretion and action. Diabetes. 2001;50:2013–2020
  45. Lear SA, Chen MM, Frohlich JJ, Birmingham CL. The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. Metabolism. 2002;51:1427–1432
  46. Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, et al. Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int. J. Obes. Relat. Metab. Disord. 2002;26:1232–1238
  47. Kang ES, Kim HJ, Ahn CW, Park CW, Cha BS, Lim SK, et al. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diab. Res. Clin. Pract. 2005;69:151–159

PII: S0168-8227(06)00038-6

doi: 10.1016/j.diabres.2006.01.011

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 268-275 , September 2006

Article Tools